MarketPeel
Insider Trading Intelligence
KR

Kristian Reich

MLTX
CHIEF SCIENTIFIC OFFICER · MOONLAKE IMMUNOTHERAPEUTICS · CIK 0001920553
FILING MIX · LIFETIME21%/79%
BUYS
9
SELLS
33
TOTAL VALUE
$17.27M
COMPANIES
1
ACTIVE SINCE
Apr 2023
HOLDINGS NOW
2,824,551
AVG SELL PX
$31.23
TRADE KIND
SHOWING 42 / 42
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kristian Reich, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+80.00%-8.13%+0.77%-8.90%-12.21%
14d15+100.00%-14.61%+1.74%-16.35%-17.87%
30d15+100.00%-12.84%+3.28%-16.12%-15.22%
60d15+86.67%-21.65%+0.85%-22.49%-24.22%
90d15+86.67%-22.22%+5.00%-27.23%-34.31%
180d15+86.67%-11.83%+10.46%-22.28%-24.53%
1y15(2 pending)+100.00%-25.66%+22.13%-47.78%-49.06%
2y15(2 pending)+100.00%-69.89%+38.90%-108.78%-107.06%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MLTX · 2,824,551 shares · as of Jun 17, 2026
0756,8711,513,7422,270,6123,027,483202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 33 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
50,000$19.43$971.5K2,824,551Jun 17, 2026Jun 17, 2026View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
50,000$18.70$935.0K2,874,551Jun 16, 2026Jun 17, 2026View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
50,000$18.89$944.5K2,924,551Jun 15, 2026Jun 17, 2026View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASEGRANT
Stock grant
520,342520,342Jan 7, 2026Jan 9, 2026View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
35,38935,389Dec 19, 2025Dec 22, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
35,3890Dec 19, 2025Dec 22, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
1,0520Dec 19, 2025Dec 22, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
72,908$14.43$1.05M0Dec 9, 2025Dec 10, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
130,000$15.08$1.96M72,908Dec 8, 2025Dec 10, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
48,97835,389Sep 2, 2025Sep 4, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
48,978202,908Sep 2, 2025Sep 4, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASEGRANT
Stock grant
139,273139,273Feb 27, 2025Mar 3, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
111,949153,930Jan 20, 2025Jan 22, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
3,3282,508Jan 20, 2025Jan 22, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
111,94984,367Jan 20, 2025Jan 22, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
1,4561,052Jan 20, 2025Sep 4, 2025View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
31,910$55.00$1.76M2,925,573Feb 28, 2024Feb 29, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
28,090$55.00$1.54M41,981Feb 28, 2024Feb 29, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
29,431$55.00$1.62M70,071Feb 27, 2024Feb 29, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
29,491$55.00$1.62M2,957,483Feb 27, 2024Feb 29, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
569$55.30$31.5K99,502Feb 21, 2024Feb 22, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
509$55.31$28.2K2,986,974Feb 21, 2024Feb 22, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$57.43$574.3K100,071Feb 20, 2024Feb 22, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$57.45$574.5K2,987,483Feb 20, 2024Feb 22, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$60.15$601.5K110,071Feb 16, 2024Feb 16, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$60.15$601.5K2,997,483Feb 16, 2024Feb 16, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$60.17$601.7K3,007,483Feb 15, 2024Feb 16, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$60.16$601.6K120,071Feb 15, 2024Feb 16, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$62.42$624.2K3,017,483Feb 14, 2024Feb 16, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE10b5-1
10b5-1 plan
10,000$62.43$624.3K130,071Feb 14, 2024Feb 16, 2024View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
41,981140,071Oct 1, 2023Oct 3, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
2,527,4770Oct 1, 2023Oct 3, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
41,981196,316Oct 1, 2023Oct 3, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
1,2485,836Oct 1, 2023Oct 3, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
75,1360Oct 1, 2023Oct 3, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
2,527,4773,027,483Oct 1, 2023Oct 3, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
98,09098,090Apr 5, 2023Apr 7, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
98,090238,297Apr 5, 2023Apr 7, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
500,0062,527,477Apr 5, 2023Apr 7, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASE
Chief Scientific Officer
500,006500,006Apr 5, 2023Apr 7, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
14,86475,136Apr 5, 2023Apr 7, 2023View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
Chief Scientific Officer
2,9167,084Apr 5, 2023Apr 7, 2023View →
Other insiders · MLTX
Loading peer insiders…
About this filer
CIK 0001920553
ROLE
Chief Scientific Officer
PRIMARY
MLTX
COMPANIES
1
ACTIVE SINCE
Apr 2023
MARKETPEEL · /INSIDER/0001920553DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback